Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis

Author:

Zaman Shafquat1,Akingboye Akinfemi2,Mohamedahmed Ali Yasen Y3ORCID,Peterknecht Elizabeth4,Bhattacharya Pratik4,El-Asrag Mohammed E15,Iqbal Tariq H67,Quraishi Mohammed Nabil17ORCID,Beggs Andrew D17ORCID

Affiliation:

1. Institute of Cancer and Genomic Science, College of Medical and Dental Science, University of Birmingham , Birmingham , UK

2. Department of General Surgery, Russells Hall Hospital , Dudley , UK

3. Department of Colorectal Surgery , Royal Wolverhampton NHS Trust, Wolverhampton , UK

4. Department of General Surgery, Sandwell and West Birmingham Hospitals , Birmingham , UK

5. Faculty of Science, Benha University , Benha , Egypt

6. Institute of Microbiology and Infection, College of Medical and Dental Science, University of Birmingham , Birmingham , UK

7. Microbiome Treatment Centre, University of Birmingham , Birmingham , UK

Abstract

Abstract Background The aim of this systematic review and meta-analysis is to assess the efficacy and safety of faecal microbiota transplantation [FMT] in the treatment of chronic pouchitis. Methods A PRISMA-compliant systematic review and meta-analysis was conducted using the following databases and clinical trial registers: Medline, Embase, Scopus, Cochrane Database of Systematic Reviews [CENTRAL], clinical trials.gov, ScienceDirect, and VHL [virtual health library]. The primary outcome was clinical response/remission in patients treated with FMT. Secondary outcomes included safety profile, quality of life, and changes in the gut microbiome. Results Seven observational cohort studies/case series and two randomised, controlled trials with a total of 103 patients were included. The route, preparation, and quantity of FMT administered varied among the included studies. Clinical response rate of 42.6% with a remission rate of 29.8% was estimated in our cohort following FMT therapy. Minor, self-limiting, adverse events were reported, and the treatment was well tolerated with good short- and long-term safety profiles. Successful FMT engraftment in recipients varied and, on average, microbial richness and diversity was lower in patients with pouchitis. In some instances, shifts with specific changes towards abundance of species, suggestive of a ‘healthier’ pouch microbiota, were observed following treatment with FMT. Conclusion The evidence for FMT in the treatment of chronic pouchitis is sparse, which limits any recommendations being made for its use in clinical practice. Current evidence from low-quality studies suggests a variable clinical response and remission rate, but the treatment is well tolerated, with a good safety profile. This review emphasises the need for rationally designed, well-powered, randomised, placebo-controlled trials to understand the efficacy of FMT for the treatment of pouchitis.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference46 articles.

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3